TAK-834-4008: Quantitative Testing of Patient and Healthcare Provider Knowledge, Attitudes, and Behavior About NATPARA® (Parathyroid Hormone) for Injection, for Subcutaneous Use (NATPARA KAB)

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Other
• If ‘other’, further details on the scope of the study:
  Knowledge, Attitude, Behavior Survey

Non-interventional study

• Non-interventional study design:
  Other
• Non-interventional study design, other:
  Survey

Study drug and medical condition

• Medical condition to be studied:
  Hypoparathyroidism

Population studied

• Age groups:
  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Estimated number of subjects:
  200

Study design details

• Main study objective:
  The main aim of this study is to check level of knowledge and assess attitudes and behaviors of both participants and physicians regarding the risks and safe use of NATPARA. The survey will be done via internet, telephone, or paper and participants will be able to choose the method that is preferred.
• Outcomes:
  Number of Participants and Prescribers Providing Correct Responses to Questions, Number of Participants and Prescribers Providing At Least 80 Percent (%) Correct Responses to Each Key Risk Message and who Demonstrated Understanding of Each Key Risk Message
• Data analysis plan:
  Data from all respondents who access the survey will be collected. Only data from those survey respondents who were eligible to participate in the survey and answered all questions (“completers”) will be analyzed. Counts and percentages will be calculated for each question/item in the questionnaire. P-values for comparison of how representative the respective survey respondents are of the respective stakeholder population will be obtained from the chi-square test.